Events Exposure as a Trigger of the Clinical Manifestations of Parkinson's Disease
1 other identifier
observational
300
1 country
1
Brief Summary
Stress has been implicated as a trigger of many diseases, throughout different mechanisms. Potentially traumatic/stressful events exposure might be a factor that triggers subclinical disabilities related to PD becoming evident to the patient. In this observational study, the investigators will evaluate with a validated events exposure questionnaire the occurrence and severity of potentially traumatic or stressful events in Parkinson's disease patients and in patients with recent-onset parkinsonism.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 6, 2020
CompletedFirst Submitted
Initial submission to the registry
March 24, 2022
CompletedFirst Posted
Study publicly available on registry
April 4, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 26, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 27, 2022
CompletedJuly 27, 2022
March 1, 2022
2.6 years
March 24, 2022
July 25, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Recruitment of 300 participants
36 months
Study Arms (3)
Parkinson´s disease individuals
Individuals with recent-onset parkinsonism
Healthy individuals
Interventions
Events exposure questionnaire that assess the occurrence of exposure to events and their severity over a limited period
Eligibility Criteria
Clinically diagnosed Parkinson's Disease (PD) patients and patients with recent-onset parkinsonism
You may qualify if:
- Informed consent is obtained from the participant
- The participant is clinically diagnosed with Parkinson's disease
- The participant has recent-onset parkinsonism
You may not qualify if:
- Participants with parkinsonism with more than 4 years of evolution of the disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
FLENI
Buenos Aires, Buenos Aires F.D., 1428, Argentina
Related Publications (1)
Paez-Maggio M, Rossi M, Fazzito L, Merello M. Validation of an events exposure questionnaire for individuals living in major cities of Argentina. Eur J Psychotraumatol. 2022 Feb 15;13(1):2031830. doi: 10.1080/20008198.2022.2031830. eCollection 2022.
PMID: 35186218RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD - Co-investigator - Clinical Professor
Study Record Dates
First Submitted
March 24, 2022
First Posted
April 4, 2022
Study Start
January 6, 2020
Primary Completion
July 26, 2022
Study Completion
July 27, 2022
Last Updated
July 27, 2022
Record last verified: 2022-03
Data Sharing
- IPD Sharing
- Will not share
The plan will be defined at a later stages